ArticleBMC psychiatry2026
Blunted niacin skin flushing response with subtype-specific clinical associations in adolescent bipolar disorder.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundBipolar disorder (BD) typically emerges during adolescence and is associated with substantial functional impairment, but objective physiological markers are scarce. The niacin skin flushing response (NSFR) has been proposed as a potential biomarker in adults with BD. However, its characteristics in adolescents and its multivariate associations with behavioral phenotypes, particularly across BD subtypes, remain poorly characterized.
methodsWe recruited 402 adolescents (184 with BD [63 BD-I, 121 BD-II]; 218 healthy controls) and conducted quantitative niacin testing. Participants underwent comprehensive assessments of clinical symptoms and cognitive function. Generalized estimating equations and multiple linear regression analyses were performed to assess group differences. Machine learning models were applied for exploratory assessment of classification performance, and sparse canonical correlation analysis (SCCA) was used to identify multivariate associations between NSFR and behavioral dimensions.
resultsAdolescents with BD exhibited a significantly attenuated and delayed NSFR compared to HCs, showing an impairment gradient: BD-II showed the most severe deficits, followed by BD-I. Machine learning models demonstrated moderate performance in distinguishing BD from HCs (cvAUC = 0.740–0.741), with limited discrimination between BD-I and BD-II (cvAUC = 0.576–0.603). SCCA revealed distinct subtype-specific patterns: in BD-I, blunted NSFR was associated with activation, mania, anxiety-depression and processing speed impairments; in BD-II, blunted NSFR was linked to anergia, insomnia, somatic anxiety, depression, activation, anhedonia, and impairments in processing speed and social cognition.
conclusionNSFR may serve as a potential screening biomarker for the early detection of adolescent BD. While it may not be suitable for stratifying BD subtypes, NSFR may reflect the physiological basis of the psychopathology underlying these subtypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.